Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: lazarre who wrote (121)	4/6/1998 8:26:00 PM
From: Anthony Wong	Respond to of 642

Lazarre, have to rely on you to watch the program and post any info relevant to LLY. Thanks in advance. Anthony

To: lazarre who wrote (121)	4/6/1998 9:09:00 PM
From: Anthony Wong	Read Replies (3) \| Respond to of 642

Lazarre , I managed to watch most of the program after all. I seem to hear, or was I wrong, that one of the guests interviewed was a Dr. Hayes who is involved in a Evista study (on the drug as prevention for breast cancer). Hadn't really mentioned Evista other than there might be safer second generation CERNs than Tamoxifen in prevention of breast cancer. Overall quite educational for a layman like me. In this case, shouldn't there be more enthusiasm for Evista? ZEN was up nearly $10 today.